These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6601292

  • 21. T cell phenotype alterations in hepatosplenic schistosomiasis mansoni normalize after chemotherapy.
    Zwingenberger K, Harms G, Vergetti de Siqueira JG, Correia Dacal AR, Jansen-Rosseck R, Bienzle U, Feldmeier H.
    Immunobiology; 1989 Oct; 179(4-5):342-52. PubMed ID: 2515152
    [Abstract] [Full Text] [Related]

  • 22. Immune responses during human schistosomiasis mansoni. XVI. Idiotypic differences in antibody preparations from patients with different clinical forms of infection.
    Montesano MA, Lima MS, Correa-Oliveira R, Gazzinelli G, Colley DG.
    J Immunol; 1989 Apr 01; 142(7):2501-6. PubMed ID: 2494260
    [Abstract] [Full Text] [Related]

  • 23. Immunological studies in human schistosomiasis. III. Immunoglobulin levels, antibodies, and delayed hypersensitivity.
    Camus D, Carlier Y, Capron M, Bina JC, Figueiredo JF, Prata A, Capron A.
    Am J Trop Med Hyg; 1977 May 01; 26(3):482-90. PubMed ID: 326069
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prolonged skin allograft survival in chronic schistosomiasis.
    Aboul-Enein A, Butt K, Abboud A, Kotkata H.
    Surgery; 1982 Apr 01; 91(4):425-9. PubMed ID: 7038958
    [No Abstract] [Full Text] [Related]

  • 26. A preliminary study on the effect of iron-deficiency anaemia and hypoproteinaemia on cell- mediated immune response in hepatosplenic schistosomiasis.
    Omran SA, Elkalouby AH, Shaker ZA, Elattar GM, Abdelwahab KS, Elraziky EH.
    J Egypt Med Assoc; 1978 Apr 01; 61(11-12):795-802. PubMed ID: 556083
    [No Abstract] [Full Text] [Related]

  • 27. Peripheral lymphocytes in patients with intestinal schistosomiasis mansoni.
    Machado JA, Silva EN, Katz N, Rocha RS, Gazzinelli G.
    Trans R Soc Trop Med Hyg; 1978 Apr 01; 72(4):441. PubMed ID: 705850
    [No Abstract] [Full Text] [Related]

  • 28. Clinical forms of human Schistosoma mansoni infection are associated with differential activation of T-cell subsets and costimulatory molecules.
    Martins-Filho OA, Cunha-Melo JR, Lambertucci JR, Silveira AM, Colley DG, Gazzinelli G, Correa-Oliveira R.
    Dig Dis Sci; 1999 Mar 01; 44(3):570-7. PubMed ID: 10080152
    [Abstract] [Full Text] [Related]

  • 29. Chronic hepatitis B antigenaemia in patients with hepatosplenic schistosomiasis.
    Bassily S, Farid Z, Higashi GI, Kamel IA, El-Masry NA, Watten RH.
    J Trop Med Hyg; 1979 Mar 01; 82(11-12):248-51. PubMed ID: 529349
    [Abstract] [Full Text] [Related]

  • 30. Immunological changes in splenectomized versus non splenectomized schistosomal hepatosplenic cases.
    Salem SA, Makled MK, Abel-Wahab MF, Sedky A, Montasser MF, Bishara SA, Ragheb MM, Younis TA.
    J Egypt Soc Parasitol; 1987 Dec 01; 17(2):785-96. PubMed ID: 3121771
    [No Abstract] [Full Text] [Related]

  • 31. Accessory cell function of liver granuloma macrophages of Schistosoma mansoni-infected mice.
    Schook LB, Wellhausen SR, Boros DL, Niederhuber JE.
    Infect Immun; 1983 Dec 01; 42(3):882-6. PubMed ID: 6605931
    [Abstract] [Full Text] [Related]

  • 32. Association of hepatosplenic schistosomiasis with HLA-DQB1*0201.
    Secor WE, del Corral H, dos Reis MG, Ramos EA, Zimon AE, Matos EP, Reis EA, do Carmo TM, Hirayama K, David RA, David JR, Harn DA.
    J Infect Dis; 1996 Nov 01; 174(5):1131-5. PubMed ID: 8896524
    [Abstract] [Full Text] [Related]

  • 33. Immune responses during human Schistosomiasis mansoni. XI. Immunologic status of patients with acute infections and after treatment.
    Gazzinelli G, Lambertucci JR, Katz N, Rocha RS, Lima MS, Colley DG.
    J Immunol; 1985 Sep 01; 135(3):2121-7. PubMed ID: 4020142
    [Abstract] [Full Text] [Related]

  • 34. Liver involvement in human schistosomiasis mansoni. Regression of immunological and biochemical disease markers after specific treatment.
    Zwingenberger K, Harms G, Feldmeier H, Müller O, Steiner A, Bienzle U.
    Acta Trop; 1988 Sep 01; 45(3):263-75. PubMed ID: 2903628
    [Abstract] [Full Text] [Related]

  • 35. Nitric oxide monocyte production levels in patients with the hepatosplenic form of schistosomiasis mansoni who underwent splenectomy, ligature of the left gastric vein and auto implantation of spleen tissue in the major omentum.
    Brandt CT, Leite CR, Manhaes-de-Castro FM, Macedo EM, Silva RP, Castro CM.
    Acta Cir Bras; 2006 Sep 01; 21(5):285-90. PubMed ID: 16981030
    [Abstract] [Full Text] [Related]

  • 36. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL, Lazdins JK, Hieny S, Natovitz P.
    J Immunol; 1983 Sep 01; 131(3):1481-6. PubMed ID: 6350456
    [Abstract] [Full Text] [Related]

  • 37. Immunity and immunopathology following reinfection of mice cured of chronic schistosomiasis mansoni.
    Warren KS, Pelley RP, Mahmoud AA.
    Am J Trop Med Hyg; 1977 Sep 01; 26(5 Pt 1):957-62. PubMed ID: 907055
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Tumour necrosis factor in hepatosplenic schistosomiasis.
    Zwingenberger K, Irschick E, Vergetti Siqueira JG, Correia Dacal AR, Feldmeier H.
    Scand J Immunol; 1990 Feb 01; 31(2):205-11. PubMed ID: 2106723
    [Abstract] [Full Text] [Related]

  • 40. Some genetic, clinical and immunologic interrelations in schistosomiasis mansoni.
    Assaad-Khalil SH, Helmy MA, Zaki A, Mikhail MM, el-Hai MA, el-Sawy M.
    Ann Biol Clin (Paris); 1993 Feb 01; 51(6):619-26. PubMed ID: 8172401
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.